BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 22032326)

  • 1. SPAK/OSR1 regulate NKCC1 and WNK activity: analysis of WNK isoform interactions and activation by T-loop trans-autophosphorylation.
    Thastrup JO; Rafiqi FH; Vitari AC; Pozo-Guisado E; Deak M; Mehellou Y; Alessi DR
    Biochem J; 2012 Jan; 441(1):325-37. PubMed ID: 22032326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional interactions of the SPAK/OSR1 kinases with their upstream activator WNK1 and downstream substrate NKCC1.
    Vitari AC; Thastrup J; Rafiqi FH; Deak M; Morrice NA; Karlsson HK; Alessi DR
    Biochem J; 2006 Jul; 397(1):223-31. PubMed ID: 16669787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions with WNK (with no lysine) family members regulate oxidative stress response 1 and ion co-transporter activity.
    Sengupta S; Tu SW; Wedin K; Earnest S; Stippec S; Luby-Phelps K; Cobb MH
    J Biol Chem; 2012 Nov; 287(45):37868-79. PubMed ID: 22989884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases.
    Vitari AC; Deak M; Morrice NA; Alessi DR
    Biochem J; 2005 Oct; 391(Pt 1):17-24. PubMed ID: 16083423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.
    Ohta A; Schumacher FR; Mehellou Y; Johnson C; Knebel A; Macartney TJ; Wood NT; Alessi DR; Kurz T
    Biochem J; 2013 Apr; 451(1):111-22. PubMed ID: 23387299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters.
    de Los Heros P; Alessi DR; Gourlay R; Campbell DG; Deak M; Macartney TJ; Kahle KT; Zhang J
    Biochem J; 2014 Mar; 458(3):559-73. PubMed ID: 24393035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1.
    Moriguchi T; Urushiyama S; Hisamoto N; Iemura S; Uchida S; Natsume T; Matsumoto K; Shibuya H
    J Biol Chem; 2005 Dec; 280(52):42685-93. PubMed ID: 16263722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WNK1 and OSR1 regulate the Na+, K+, 2Cl- cotransporter in HeLa cells.
    Anselmo AN; Earnest S; Chen W; Juang YC; Kim SC; Zhao Y; Cobb MH
    Proc Natl Acad Sci U S A; 2006 Jul; 103(29):10883-8. PubMed ID: 16832045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. With no lysine L-WNK1 isoforms are negative regulators of the K+-Cl- cotransporters.
    Mercado A; de Los Heros P; Melo Z; Chávez-Canales M; Murillo-de-Ozores AR; Moreno E; Bazúa-Valenti S; Vázquez N; Hadchouel J; Gamba G
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C54-66. PubMed ID: 27170636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The WNK-SPAK/OSR1 pathway: master regulator of cation-chloride cotransporters.
    Alessi DR; Zhang J; Khanna A; Hochdörfer T; Shang Y; Kahle KT
    Sci Signal; 2014 Jul; 7(334):re3. PubMed ID: 25028718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cotransporters, WNKs and hypertension: an update.
    Flatman PW
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):186-92. PubMed ID: 18277153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of heterozygous deletion of WNK1 on the WNK-OSR1/ SPAK-NCC/NKCC1/NKCC2 signal cascade in the kidney and blood vessels.
    Susa K; Kita S; Iwamoto T; Yang SS; Lin SH; Ohta A; Sohara E; Rai T; Sasaki S; Alessi DR; Uchida S
    Clin Exp Nephrol; 2012 Aug; 16(4):530-8. PubMed ID: 22294159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the thiazide-sensitive Na+-Cl- cotransporter by the WNK-regulated kinases SPAK and OSR1.
    Richardson C; Rafiqi FH; Karlsson HK; Moleleki N; Vandewalle A; Campbell DG; Morrice NA; Alessi DR
    J Cell Sci; 2008 Mar; 121(Pt 5):675-84. PubMed ID: 18270262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of WNK1-SPAK/OSR1 Attenuates Bone Cancer Pain by Regulating NKCC1 and KCC2.
    Gao JL; Peng K; Shen MW; Hou YH; Qian XB; Meng XW; Ji FH; Wang LN; Yang JP
    J Pain; 2019 Dec; 20(12):1416-1428. PubMed ID: 31085334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of WNK1 knockout cell lines by CRISPR/Cas-mediated genome editing.
    Roy A; Goodman JH; Begum G; Donnelly BF; Pittman G; Weinman EJ; Sun D; Subramanya AR
    Am J Physiol Renal Physiol; 2015 Feb; 308(4):F366-76. PubMed ID: 25477473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WNK bodies cluster WNK4 and SPAK/OSR1 to promote NCC activation in hypokalemia.
    Thomson MN; Cuevas CA; Bewarder TM; Dittmayer C; Miller LN; Si J; Cornelius RJ; Su XT; Yang CL; McCormick JA; Hadchouel J; Ellison DH; Bachmann S; Mutig K
    Am J Physiol Renal Physiol; 2020 Jan; 318(1):F216-F228. PubMed ID: 31736353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 signalling pathway.
    Richardson C; Alessi DR
    J Cell Sci; 2008 Oct; 121(Pt 20):3293-304. PubMed ID: 18843116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the NKCC2 ion cotransporter by SPAK-OSR1-dependent and -independent pathways.
    Richardson C; Sakamoto K; de los Heros P; Deak M; Campbell DG; Prescott AR; Alessi DR
    J Cell Sci; 2011 Mar; 124(Pt 5):789-800. PubMed ID: 21321328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel Ste20-related proline/alanine-rich kinase (SPAK)-independent pathway involving calcium-binding protein 39 (Cab39) and serine threonine kinase with no lysine member 4 (WNK4) in the activation of Na-K-Cl cotransporters.
    Ponce-Coria J; Markadieu N; Austin TM; Flammang L; Rios K; Welling PA; Delpire E
    J Biol Chem; 2014 Jun; 289(25):17680-8. PubMed ID: 24811174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WNK1-OSR1 kinase-mediated phospho-activation of Na+-K+-2Cl- cotransporter facilitates glioma migration.
    Zhu W; Begum G; Pointer K; Clark PA; Yang SS; Lin SH; Kahle KT; Kuo JS; Sun D
    Mol Cancer; 2014 Feb; 13():31. PubMed ID: 24555568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.